We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $30.1B
1-Year Est. Return 30.03%
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
+30.03%
3 Year Est. Return
+88.6%
5 Year Est. Return
+115.14%
10 Year Est. Return
+349.12%
AUM
$26.6B
AUM Growth
-$451M
Cap. Flow
-$6.98B
Cap. Flow %
-26.2%
Top 10 Hldgs %
27.19%
Holding
1,021
New
103
Increased
183
Reduced
320
Closed
97

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$99.2M
2
ORCL icon
Oracle
ORCL
+$51.7M
3
NVDA icon
NVIDIA
NVDA
+$48.6M
4
K
Kellanova
K
+$39M
5
MSFT icon
Microsoft
MSFT
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 21.94%
2 Financials 7.55%
3 Communication Services 7.22%
4 Consumer Discretionary 6.94%
5 Healthcare 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CP icon
276
Canadian Pacific Kansas City
CP
$80.5B
$9.57M 0.04%
129,955
+123
+0.1% +$9.05K
MTB icon
277
M&T Bank
MTB
$36.2B
$9.56M 0.04%
47,462
-1,927
-4% -$368K
URBN icon
278
CALL
Urban Outfitters
URBN
$6.59B
$9.46M 0.04%
+132,500
New +$9.37M
DAVE icon
279
Dave Inc
DAVE
$4.06B
$9.42M 0.04%
42,550
+5,483
+15% +$1.18M
TGT icon
280
Target
TGT
$68B
$9.4M 0.04%
96,138
-3,903
-4% -$360K
DRI icon
281
Darden Restaurants
DRI
$24.4B
$9.32M 0.04%
50,672
-2,058
-4% -$375K
STT icon
282
State Street
STT
$50.7B
$9.26M 0.03%
71,800
-2,915
-4% -$349K
RSI icon
283
Rush Street Interactive
RSI
$2.88B
$9.15M 0.03%
470,971
+61,405
+15% +$1.13M
MAS icon
284
Masco
MAS
$15.3B
$9.12M 0.03%
143,750
-5,827
-4% -$378K
REGN icon
285
Regeneron Pharmaceuticals
REGN
$80.8B
$9.1M 0.03%
11,793
-479
-4% -$325K
HUM icon
286
Humana
HUM
$46.2B
$9.1M 0.03%
35,510
-1,192
-3% -$312K
PSX icon
287
Phillips 66
PSX
$81.4B
$8.92M 0.03%
69,137
-2,807
-4% -$378K
NI icon
288
NiSource
NI
$20.4B
$8.89M 0.03%
212,955
-8,648
-4% -$369K
MDT icon
289
CALL
Medtronic
MDT
$112B
$8.86M 0.03%
+93,000
New +$9.03M
NCLH icon
290
Norwegian Cruise Line
NCLH
$8.84B
$8.79M 0.03%
393,795
-15,992
-4% -$338K
GEHC icon
291
GE HealthCare
GEHC
$32.4B
$8.78M 0.03%
107,091
-2,491
-2% -$194K
KMB icon
292
Kimberly-Clark
KMB
$36.5B
$8.7M 0.03%
86,268
-3,503
-4% -$383K
POLE
293
Andretti Acquisition Corp II
POLE
$319M
$8.7M 0.03%
825,000
BABA icon
294
Alibaba
BABA
$308B
$8.6M 0.03%
58,704
+7,902
+16% +$1.29M
TASK icon
295
TaskUs
TASK
$669M
$8.55M 0.03%
+725,086
New +$9.27M
AVY icon
296
Avery Dennison
AVY
$13.4B
$8.47M 0.03%
46,581
-1,892
-4% -$327K
BLKB icon
297
Blackbaud
BLKB
$2.08B
$8.42M 0.03%
133,042
-3,692
-3% -$228K
ADM icon
298
Archer Daniels Midland
ADM
$36.9B
$8.33M 0.03%
144,895
-5,884
-4% -$352K
PSA icon
299
Public Storage
PSA
$61.3B
$8.29M 0.03%
31,946
-1,297
-4% -$363K
SITM icon
300
SiTime
SITM
$21.8B
$8.15M 0.03%
23,080
+1,678
+8% +$525K

Similar funds

Calamos Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Calamos Advisors held 1,021 positions worth $26.6B, down 1.7% from $27.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Calamos Advisors withdrew a net $6.98B in Q4 2025, closing 97 positions and reducing 320 holdings. Its most notable exit was Kellanova, an estimated $39M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 22% a quarter earlier, followed by Financials and Communication Services.

Against the trend, Calamos Advisors opened a new position in The Southern Company 2025 Series A Corp Units worth $125M.

  • Calamos Advisors's largest Q4 2025 buy was The Southern Company 2025 Series A Corp Units: 2,485,706 shares worth $125M.
  • Calamos Advisors added most to IQVIA in Q4 2025, an estimated $29.9M increase.
  • Calamos Advisors's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $99.2M.
  • Calamos Advisors fully exited Kellanova in Q4 2025, selling an estimated $39M.
  • Calamos Advisors's ten largest holdings make up 27% of its $26.6B portfolio in Q4 2025.
  • Calamos Advisors opened 103 new positions and closed 97 in Q4 2025.
  • Calamos Advisors's portfolio value fell 1.7% quarter-over-quarter to $26.6B.

Based on Calamos Advisors's 13F filing for Q4 2025, filed 29 Jan 2026.